The latest surge of Covid-19 infections has pushed the seven-day average of new daily cases to heights not seen since the pandemic began.

The US Food and Drug Administration approved remdesivir for the treatment of coronavirus infection, the drug's maker, Gilead Sciences, said Thursday.

The hunt for kids COVID-19 vaccine is only just beginning, and some U.S. pediatricians are worried it might not be ready in time for the next school year.

U.K. researchers are preparing to infect healthy young volunteers with the new coronavirus to study the disease in hopes of speeding up development of a vaccine.

State health officials have formally submitted their plan to distribute the COVID-19 vaccine whenever one becomes available.

New research from BYU looks at whether or not people will get a vaccine for the coronavirus, and what may be standing in their way.

A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot.

A rising rate of COVID-19 infection and a high number of new daily cases have hospital administrators very worried about being able to keep up with demand. 

Doctors have come up with a new system that could spot potential complications, and give doctors a better idea of how COVID-19 patients need to be treated.

Johnson & Johnson is beginning a huge final-stage study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. It will be one of the world’s largest coronavirus vaccine studies so far, testing in 60,000 volunteers in the U.S., South Africa, Argentina, Brazil, Chile, Colombia, Mexico and Peru.